Last checked at 3 Jan 2018 07:00
3 January 2018
Accrol Group Holdings plc
(the "Company")
Notice of Half Year Results
and
Analyst Briefing
Accrol Group Holdings plc (AIM: ACRL), the AIM listed independent tissue converter and supplier to some of the UK's largest retailers, will announce its Half Year Results for the six months ended 30 October 2017 on Monday, 22 January 2018, including an update on the Company's progress since the £18m fundraising announced on 20 November 2017.
The Company will hold an analyst briefing at 9.30am on the day of its results. Analysts interested in attending the briefing should contact Belvedere Communications for details.
For further information, please contact: |
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
Belvedere Communications Limited |
|
Cat Valentine (cvalentine@belvederepr.com) Kim van Beeck (kvbeeck@belvederepr.com) | Tel: +44 (0) 7715 769 078 Tel: +44 (0) 203 567 0510 |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers.
Accrol operates from three sites:
· a 350,000 sq ft manufacturing, storage and distribution facility in Blackburn;
· a 70,000 sq ft facial tissue plant, also in Blackburn; and
· a 168,000 sq ft manufacturing, storage and distribution facility in Leyland.
In addition, the business has a 368,000 sq ft storage and distribution facility in Skelmersdale, Lancashire.
Accrol manufactures approximately 18 million units per week, supplying customers with both Accrol branded and "private label" products.